Search Results - "Flam, T."

Refine Results
  1. 1

    Transcriptomes of antigen presenting cells in human thymus by Gabrielsen, Ingvild S M, Helgeland, Hanna, Akselsen, Helle, D Aass, Hans Christian, Sundaram, Arvind Y M, Snowhite, Isaac V, Pugliese, Alberto, Flåm, Siri T, Lie, Benedicte A

    Published in PloS one (01-07-2019)
    “…Antigen presenting cells (APCs) in the thymus play an essential role in the establishment of central tolerance, i.e. the generation of a repertoire of…”
    Get full text
    Journal Article
  2. 2

    Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) by Lande, Asgeir, Fluge, Øystein, Strand, Elin B., Flåm, Siri T., Sosa, Daysi D., Mella, Olav, Egeland, Torstein, Saugstad, Ola D., Lie, Benedicte A., Viken, Marte K.

    Published in Scientific reports (24-03-2020)
    “…The etiology and pathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are unknown, and autoimmunity is one of many proposed underlying…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients by Rydland, Anne, Heinicke, Fatima, Flåm, Siri T., Mjaavatten, Maria D., Lie, Benedicte A.

    “…Extracellular vesicles (EVs) are implicated in the pathogenesis of rheumatoid arthritis (RA) but little is known about the composition of specific small EV…”
    Get full text
    Journal Article
  8. 8

    Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation by Meraouna, Y., Blanchard, P., Losa, S., Labib, A., Krhili, S., Pommier, P., Crehange, G., Flam, T., Cosset, J-M., Kissel, M.

    “…•94 patients with isolated local relapse of prostate cancer after definitive irradiation.•Salvage I-125 low-dose-rate brachytherapy was performed in a…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Endorectal 3D T2-weighted 1 mm-slice thickness MRI for prostate cancer staging at 1.5 Tesla: Should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria? by Cornud, F, Rouanne, M, Beuvon, F, Eiss, D, Flam, T, Liberatore, M, Zerbib, M, Delongchamps, N.B

    Published in European journal of radiology (01-04-2012)
    “…Abstract Purpose To evaluate the accuracy of a 3D-endorectal 1 mm-thick slices MRI acquisition for local staging of low, intermediate and high D’Amico risk…”
    Get full text
    Journal Article
  12. 12

    Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer by Delongchamps, N B, Beuvon, F, Eiss, D, Flam, T, Muradyan, N, Zerbib, M, Peyromaure, M, Cornud, F

    Published in Prostate cancer and prostatic diseases (01-09-2011)
    “…To study the staging accuracy of multiparametric magnetic resonance imaging (MRI) in patients showing unilateral low-risk cancer on prostate biopsy. A total of…”
    Get full text
    Journal Article
  13. 13

    On change detection in a Kalman filter based tracking problem by Moussakhani, B., Flåm, J.T., Ramstad, T.A., Balasingham, I.

    Published in Signal processing (01-12-2014)
    “…This work considers detecting an additive abrupt state change in a tracking process. It is assumed that the tracking is done by a Kalman filter and that the…”
    Get full text
    Journal Article
  14. 14

    The Linear Model Under Mixed Gaussian Inputs: Designing the Transfer Matrix by Flam, John T., Zachariah, Dave, Vehkapera, Mikko, Chatterjee, Saikat

    Published in IEEE transactions on signal processing (01-11-2013)
    “…Suppose a linear model y=Hx+n, where inputs x,n are independent Gaussian mixtures. The problem is to design the transfer matrix H so as to minimize the mean…”
    Get full text
    Journal Article
  15. 15
  16. 16

    HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles by Nordang, Gry B N, Flåm, Siri T, Maehlen, Marthe T, Kvien, Tore K, Viken, Marthe K, Lie, Benedicte A

    Published in Rheumatology (Oxford, England) (01-11-2013)
    “…The MHC exerts the greatest contribution to RA susceptibility, where certain HLA-DRB1 alleles confer the greatest risk. Interestingly, there is evidence for…”
    Get full text
    Journal Article
  17. 17

    Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003 by Cosset, J.-M., Belin, L., Wakil, G., Flam, T., Thiounn, N., Pierrat, N., Pontvert, D., Savignoni, A., Chauveinc, L.

    Published in Cancer radiothérapie (01-05-2017)
    “…To analyse the rate of secondary malignancies observed in a series of 675 prostate cancer patients who underwent a permanent implant brachytherapy between 1999…”
    Get full text
    Journal Article
  18. 18

    Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: Should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria? by Cornud, F., Rouanne, M., Beuvon, F., Eiss, D., Flam, T., Liberatore, M., Zerbib, M., Delongchamps, N.B.

    Published in European journal of radiology (01-04-2012)
    “…To evaluate the accuracy of a 3D-endorectal 1mm-thick slices MRI acquisition for local staging of low, intermediate and high D’Amico risk prostate cancer…”
    Get full text
    Journal Article
  19. 19

    Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003 by Cosset, J.-M., Flam, T., Belin, L., Thiounn, N., Pierrat, N., Pontvert, D., Wakil, G., Savignoni, A., Chauveinc, L.

    Published in Cancer radiothérapie (01-06-2016)
    “…To analyse long-term overall survival, relapse-free survival and late toxicities in a series of 675 patients treated between 1999 and 2003, with a median…”
    Get full text
    Journal Article
  20. 20

    Intermittent androgen suppression in patients with prostate cancer by De La Taille, A., Zerbib, M., Conquy, S., Amsellem‐Ouazana, D., Thiounn, N., Flam, T.A., Debré, B.

    Published in BJU international (01-01-2003)
    “…OBJECTIVES To evaluate intermittent androgen suppression (IAS) in patients with prostate cancer and to try to define predictive factors for biochemical…”
    Get full text
    Journal Article